Image

EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study

EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The main aim of the present process-outcome study is to evaluate the feasibility and the effects of an EMDR-IGTP-OTS group intervention on a sample of people with cancer, by using a process-outcome study design, with repeated measures.

Description

The diagnosis of cancer represents a potentially life-threatening event that can be considered a unique traumatic stressor. A cancer diagnosis can disrupt a person's life, affecting emotions, cognition, and physical pain impacting the individual sense of identity. Findings from the literature suggest that EMDR can be a valid treatment in the processing of cancer-related traumatic events. With this proposal, the investigators aim to evaluate the feasibility and the effects of a combined EMDR Integrative Group Treatment Protocol and an optional EMDR individual protocol for people with cancer.

Eligibility

Inclusion Criteria:

  • cancer diagnosis
  • PTSD (IES-R \> 32)

Exclusion Criteria:

  • receiving specialized trauma therapy
  • receiving current psychiatric pharmacological treatment, unless the dosage has been stable for at least 2 months prior to enrollment

Study details
    Thyroid Neoplasms
    Neoplasm
    Post-traumatic Stress Disorder (PTSD)
    Psychological Distress

NCT07447089

Università Cattolica di Milano

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.